As the panelists conclude their discussion about systemic lupus erythematosus (SLE) and hemophilia, they share their perspectives about the Affordable Care Act and its potential.
Patrick F. Fogarty, MD, Hugh Fatodu, RPh, MBA, and Maria Lopes, MD, MS, raise concerns about the affordability of healthcare.
Dr Fogarty hopes that despite high treatment costs, patients with hemophilia will have access to necessary drugs and specialty hemophilia treatment centers to receive the care that they require.
Mr Fatodu discusses the need for transparency when pharmaceutical companies review orphan drug prices and explains that the cost of a drug needs to be relative to its value.
Dr Lopes believes that professionals need to work collectively to define a product’s value and determine ways to minimize overall product waste.
Michelle Petri, MD, MPH, recognizes the issues that healthcare professionals face when treating patients with SLE and explains the importance for individualized therapy.
Navigating Medicare's Part D Subsidy Program to Achieve Value-Based Care
May 26th 2023On this episode of Managed Care Cast, we speak with the lead researcher from a study published in the May 2023 issue of The American Journal of Managed Care® about the impact of low-income subsidies on the uptake and equitable use of expensive orally administered antimyeloma therapy.
Listen
Health Equity Conversations: Managing Underserved Communities and Value-Based Payment
May 23rd 2023On this episode of Managed Care Cast, we feature several leaders in diversity, equity, and inclusion advancing health equity in their respective organization’s policy and practice initiatives.
Listen
Contributor: Mental Health Conditions Rose Nationally in Share of Telehealth Claim Lines
June 5th 2023In March 2023, national telehealth utilization rose 1.8%, up from 5.5% of medical claim lines in February, according to new data from FAIR Health’s Monthly Telehealth Regional Tracker.
Read More
2 Clarke Drive
Cranbury, NJ 08512